MIA leads world-class skin tumour pathology conference
14 February 2020
World-leading skin cancer experts, headed by Co-Medical Director of Melanoma Institute Australia Professor Richard Scolyer, will converge on The University of Sydney’s Charles Perkins Centre this weekend to instruct a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
Attendees will also hear from two international melanoma experts across the breadth of the program - Professor Klaus Busam, Director of Dermatopathology at Memorial Sloan Kettering Cancer Centre, New York, and Professor Pedram Gerami, Professor of Dermatology at Northwestern University, Illinois.
MIA clinicians and researchers will provide a wealth of home-grown expertise with talks from epidemiologist Professor Anne Cust, pathologists Dr Peter Ferguson and Dr Robert Rawson, world-renowned melanoma and surgical oncologist Professor John Thompson, and Co-Medical Director of MIA Professor Georgina Long.
The course aims to provide international attendees with the latest in skin tumour pathology, discussing current best practice and new tests, along with highlighting the integration of clinical and genomic information for diagnosis, prognosis and treatment selection. The course will end with detailed examination of high-value educational cases to consolidate two days worth of world-class learnings.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.